China Universal Asset Management Company’s Alpine Immune Sciences Inc ALPN Stock Holding History

China Universal Asset Management Company’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-12,630	Closed	-$501K	–	451
2024 Q1	$501K	Buy	12,630 +5,907	+88%	+$174K	0.06%	181
2023 Q4	$128K	Buy	6,723 +5,454	+430%	+$75.8K	0.02%	252
2023 Q3	$14.5K	Buy	1,269 +640	+102%	+$7.88K	﹤0.01%	321
2023 Q2	$6.47K	Buy	629 +6	+1%	+$54	﹤0.01%	344
2023 Q1	$4.81K	Buy	623 +156	+33%	+$1.24K	﹤0.01%	368
2022 Q4	$3.43K	Buy	467 +182	+64%	+$1.16K	﹤0.01%	336
2022 Q3	$2K	Buy	+285	New	+$2.35K	﹤0.01%	371

China Universal Asset Management Company's ALPN Position: Q2 2024 in Review

China Universal Asset Management Company sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 12,630 shares — an estimated $501K sold.

China Universal Asset Management Company first reported a position in ALPN in Q3 2022 and held it in 7 quarters. The position peaked at $501K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

China Universal Asset Management Company reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
China Universal Asset Management Company sold 12,630 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $501K.
China Universal Asset Management Company first reported a position in Alpine Immune Sciences Inc in Q3 2022 and held it in 7 quarters.
China Universal Asset Management Company's Alpine Immune Sciences Inc position peaked at $501K in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on China Universal Asset Management Company's 13F filing for Q2 2024, filed 19 Jul 2024.